These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1639228)
1. Plasma concentration of paracetamol and its major metabolites after p.o. dosing with paracetamol or concurrent administration of paracetamol and its N-acetyl-DL-methionine ester in mice. Skoglund LA; Ingebrigtsen K; Lausund P; Nafstad I Gen Pharmacol; 1992 Mar; 23(2):155-8. PubMed ID: 1639228 [TBL] [Abstract][Full Text] [Related]
2. In vivo studies on toxic effects of concurrent administration of paracetamol and its N-acetyl-DL-methionine ester (SUR 2647 combination). Skoglund LA; Ingebrigtsen K; Nafstad I; Aalen O Gen Pharmacol; 1988; 19(2):213-7. PubMed ID: 3350331 [TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of paracetamol (acetaminophen) and its sulphate and glucuronide metabolites in desert camels and goats. Ali BH; Cheng Z; el Hadrami G; Bashir AK; McKellar QA J Vet Pharmacol Ther; 1996 Jun; 19(3):238-44. PubMed ID: 8803883 [TBL] [Abstract][Full Text] [Related]
4. The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis. Martin U; Temple RM; Winney RJ; Prescott LF Eur J Clin Pharmacol; 1993; 45(2):141-5. PubMed ID: 8223835 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of paracetamol-esterified methionine versus cysteine or methionine on paracetamol-induced hepatic GSH depletion and plasma ALAT level in mice. Skoglund LA; Ingebrigtsen K; Nafstad I; Aalen O Biochem Pharmacol; 1986 Sep; 35(18):3071-5. PubMed ID: 3753517 [TBL] [Abstract][Full Text] [Related]
6. Effect of nizatidine on paracetamol and its metabolites in human plasma. Itoh H; Nagano T; Takeyama M J Pharm Pharmacol; 2002 Jun; 54(6):869-73. PubMed ID: 12079004 [TBL] [Abstract][Full Text] [Related]
7. The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay. Jensen LS; Valentine J; Milne RW; Evans AM J Pharm Biomed Anal; 2004 Feb; 34(3):585-93. PubMed ID: 15127815 [TBL] [Abstract][Full Text] [Related]
8. Comparison of a traditional paracetamol medication and a new paracetamol/paracetamol-methionine ester combination. Skoglund LA; Skjelbred P Eur J Clin Pharmacol; 1984; 26(5):573-7. PubMed ID: 6468471 [TBL] [Abstract][Full Text] [Related]
9. Paracetamol and metabolite pharmacokinetics in infants. van der Marel CD; Anderson BJ; van Lingen RA; Holford NH; Pluim MA; Jansman FG; van den Anker JN; Tibboel D Eur J Clin Pharmacol; 2003 Jul; 59(3):243-51. PubMed ID: 12761605 [TBL] [Abstract][Full Text] [Related]
10. Effects of ethanol ingestion on the metabolism of a hepatotoxic dose of paracetamol in mice. Tredger JM; Smith HM; Read RB; Williams R Xenobiotica; 1986 Jul; 16(7):661-70. PubMed ID: 3751120 [TBL] [Abstract][Full Text] [Related]
11. Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants. Krekels EH; van Ham S; Allegaert K; de Hoon J; Tibboel D; Danhof M; Knibbe CA Eur J Clin Pharmacol; 2015 Sep; 71(9):1075-82. PubMed ID: 26139379 [TBL] [Abstract][Full Text] [Related]
12. Liver damage and plasma concentrations of paracetamol and its metabolites after paracetamol overdosage in mice. Esteban A; Satorres J; Mayole MJ; Graells ML; Pérez-Mateo M Methods Find Exp Clin Pharmacol; 1993 Mar; 15(2):125-30. PubMed ID: 8487595 [TBL] [Abstract][Full Text] [Related]
13. The effect of sunitinib on the plasma exposure of intravenous paracetamol and its major metabolite: paracetamol glucuronide. Karbownik A; Szałek E; Sobańska K; Połom W; Grabowski T; Biczysko-Murawa A; Matuszewski M; Wolc A; Grześkowiak E Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):163-70. PubMed ID: 24676873 [TBL] [Abstract][Full Text] [Related]
14. The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure. Martin U; Temple RM; Winney RJ; Prescott LF Eur J Clin Pharmacol; 1991; 41(1):43-6. PubMed ID: 1782975 [TBL] [Abstract][Full Text] [Related]
15. Cisapride raises the bioavailability of paracetamol by inhibiting its glucuronidation in man. Itoh H; Nagano T; Takeyama M J Pharm Pharmacol; 2001 Jul; 53(7):1041-5. PubMed ID: 11480539 [TBL] [Abstract][Full Text] [Related]
16. Reversed-phase chromatography of urinary metabolites of paracetamol using ion suppression and ion pairing. Hart SJ; Tontodonati R; Calder IC J Chromatogr; 1981 Oct; 225(2):387-405. PubMed ID: 7298773 [TBL] [Abstract][Full Text] [Related]
17. Paracetamol and its metabolites in saliva and plasma in chronic dialysis patients. Lee HS; Ti TY; Lye WC; Khoo YM; Tan CC Br J Clin Pharmacol; 1996 Jan; 41(1):41-7. PubMed ID: 8824692 [TBL] [Abstract][Full Text] [Related]
18. A new paracetamol/paracetamol-methionine ester combination effects on postoperative course. Skoglund LA Eur J Clin Pharmacol; 1986; 31(1):45-8. PubMed ID: 3780826 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice. Karbownik A; Szałek E; Sobańska K; Grabowski T; Wolc A; Grześkowiak E Eur J Pharm Sci; 2017 May; 102():55-62. PubMed ID: 28232141 [TBL] [Abstract][Full Text] [Related]
20. The estimation of paracetamol and its major metabolites in both plasma and urine by a single high-performance liquid chromatography assay. Lau GS; Critchley JA J Pharm Biomed Anal; 1994 Dec; 12(12):1563-72. PubMed ID: 7696381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]